Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses

por Laborde, Rebecca R., Lin, Yi, Gustafson, Michael P., Bulur, Peggy A., Dietz, Allan B.
Publicado 2014

Tumor Microenvironment CD14(+) Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma

por Schenk, Erin L., Boland, Jennifer M., Withers, Sarah G., Bulur, Peggy A., Dietz, Allan B.
Publicado 2022

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance

por Zhang, Zhe (Jenny), Bulur, Peggy A, Dogan, Ahmet, Gastineau, Dennis A, Dietz, Allan B, Lin, Yi
Publicado 2015

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy

por Zhang, Zhe (Jenny), Bulur, Peggy A, Gustafson, Michael P, Gastineau, Dennis A, Dietz, Allan B, Lin, Yi
Publicado 2013

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients

por Cordes, Stefan F, Gustafson, Michael P, Zhang, Zhe, Bulur, Peggy A, Gastineau, Dennis A, Lin, Yi, Dietz, Allan B
Publicado 2013

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

por Markovic, Svetomir N, Dietz, Allan B, Greiner, Carl W, Maas, Mary L, Butler, Greg W, Padley, Douglas J, Bulur, Peggy A, Allred, Jacob B, Creagan, Edward T, Ingle, James N, Gastineau, Dennis A, Vuk-Pavlovic, Stanimir
Publicado 2006